The researchers highlighted a need for the detection of more relevant markers and guidance on how to treat adverse events (AEs), the types and severity of which vary based on disease type. Amidst ...
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the ...
One powerful way cancer cells defend against tumor-killing immune cells is to load up their cell surface with a protein known as PD-L1. Now a team of researchers has identified a method to degrade ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results